:αβ

Anna Koot1,2, Rosella Hermens3, Petronella Ottevanger4

  • 1Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.

PubMed
概括

患者决策辅助工具 (PtDA) 是为面临手术或氨酸激酶抑制剂治疗决策的差异化甲状腺癌 (DTC) 患者开发的. 这些工具被发现是可以接受的,可用的,可读的,并有助于明智的决策.